| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 508 | 2015 |
| Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response E Giacomini, E Iona, L Ferroni, M Miettinen, L Fattorini, G Orefici, ... The Journal of Immunology 166 (12), 7033-7041, 2001 | 495 | 2001 |
| Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results A Van Deun, L Barrera, I Bastian, L Fattorini, H Hoffmann, KM Kam, ... Journal of clinical microbiology 47 (11), 3501-3506, 2009 | 185 | 2009 |
| rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy G Pozzi, M Meloni, E Iona, G Orru, OF Thoresen, ML Ricci, MR Oggioni, ... Journal of clinical microbiology 37 (4), 1197-1199, 1999 | 152 | 1999 |
| Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients M Merker, TA Kohl, A Roetzer, L Truebe, E Richter, S Rüsch-Gerdes, ... PloS one 8 (12), e82551, 2013 | 108 | 2013 |
| Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitumβ‐lactamase genes cloned from a natural isolate and a high … J Timm, MG Perilli, C Duez, J Trias, G Orefici, L Fattorini, G Amicosante, ... Molecular microbiology 12 (3), 491-504, 1994 | 108 | 1994 |
| Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells S Mariotti, R Teloni, E Iona, L Fattorini, F Giannoni, G Romagnoli, ... European journal of immunology 32 (11), 3050-3058, 2002 | 104 | 2002 |
| The extra cytoplasmic function sigma factor σE is essential for Mycobacterium tuberculosis virulence in mice R Manganelli, L Fattorini, D Tan, E Iona, G Orefici, G Altavilla, P Cusatelli, ... Infection and immunity 72 (5), 3038-3041, 2004 | 92 | 2004 |
| Is second-line anti-tuberculosis drug susceptibility testing reliable? SJ Kim, MA Espinal, C Abe, GH Bai, F Boulahbal, L Fattorini, C Gilpin, ... International Union Against Tuberculosis And Lung Disease, 2004 | 79 | 2004 |
| Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice L Fattorini, D Tan, E Iona, M Mattei, F Giannoni, L Brunori, S Recchia, ... Antimicrobial agents and chemotherapy 47 (1), 360-362, 2003 | 76 | 2003 |
| An anti-inflammatory role for Vα14 NK T cells in Mycobacterium bovis bacillus Calmette-Guerin-infected mice F Dieli, M Taniguchi, M Kronenberg, S Sidobre, J Ivanyi, L Fattorini, E Iona, ... The Journal of Immunology 171 (4), 1961-1968, 2003 | 72 | 2003 |
| Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis F Giannoni, E Iona, F Sementilli, L Brunori, M Pardini, GB Migliori, ... Antimicrobial agents and chemotherapy 49 (7), 2928-2933, 2005 | 71 | 2005 |
| The Mycobacterium tuberculosis sigma factor σB is required for full response to cell envelope stress and hypoxia in vitro, but it is dispensable for in vivo growth PA Fontán, MI Voskuil, M Gomez, D Tan, M Pardini, R Manganelli, ... Journal of bacteriology 191 (18), 5628-5633, 2009 | 67 | 2009 |
| Mycobacterium bovis Bacillus Calmette‐Guérin infects DC‐SIGN– dendritic cell and causes the inhibition of IL‐12 and the enhancement of IL‐10 production MC Gagliardi, R Teloni, F Giannoni, M Pardini, V Sargentini, L Brunori, ... Journal of leukocyte biology 78 (1), 106-113, 2005 | 66 | 2005 |
| Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells S Mariotti, R Teloni, E Iona, L Fattorini, G Romagnoli, MC Gagliardi, ... Infection and immunity 72 (8), 4385-4392, 2004 | 64 | 2004 |
| In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis L Fattorini, R Gennaro, M Zanetti, D Tan, L Brunori, F Giannoni, M Pardini, ... Peptides 25 (7), 1075-1077, 2004 | 62 | 2004 |
| Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions G Piccaro, F Giannoni, P Filippini, A Mustazzolu, L Fattorini Antimicrobial agents and chemotherapy 57 (3), 1428-1433, 2013 | 60 | 2013 |
| A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region D Isola, M Pardini, F Varaine, S Niemann, S Rüsch-Gerdes, L Fattorini, ... Journal of microbiological methods 62 (1), 113-120, 2005 | 55 | 2005 |
| Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient F Meacci, G Orru, E Iona, F Giannoni, C Piersimoni, G Pozzi, L Fattorini, ... Journal of clinical microbiology 43 (7), 3114-3120, 2005 | 53 | 2005 |
| Activity of 16 Antimicrobial Agents Against Drug-Resistant Strains of Mycobacterium tuberculosis L Fattorini, E Iona, ML Ricci, OF Thoresen, G Orru, MR Oggioni, E Tortoli, ... Microbial Drug Resistance 5 (4), 265-270, 1999 | 51 | 1999 |
